Trying to get a straight answer on this: does reimbursement actually matter or is it forum lore at this point. The variation between pharmacies inside my own country…
u/marit_coelho
Contributes reviews on supplier material. Based in Brno.
member · joined 13 Apr 2025
Overview — page 2 of 3
comment on [Question] how do you actually verify sulphur burps in c/sideeffects · 15 points · 10 months ago
The effect on gastric emptying is most pronounced early and attenuates with continued dosing, which is the mechanism behind the "it settles at a stable dose" pattern the whole board reports.
comment on the pharmacy thing finally clicked for me and I want to write it down in c/glp1eu · 33 points · 10 months ago
the EMA authorises, member states decide who pays
comment on [Question] the UK — has anyone got a straight answer on private prescription in c/glp1uk · 123 points · 10 months ago
Correction: that threshold is your ICB’s, not a national one. They differ and they change by year.
comment on Wegovy: what the trials say vs what this community says in c/semaglutide · 70 points · 10 months ago
What dose and how many weeks at it before this started?
comment on switched from 1.0mg to 2.4mg and fatigue got better, not worse in c/sideeffects · 165 points · 10 months ago
Yes. Holding the dose is a real option and it does not mean you have failed at anything.
comment on special authorization is the most under-discussed thing on this board in c/glp1canada · 1 points · 11 months ago
Employer-sponsored plans have their own criteria and appeal processes, independent of the provincial formulary. Which one applies determines everything about the route.
comment on am I the only one who found orforglipron harder than the injections in c/orforglipron · 26 points · 11 months ago
Spent an evening reading about small-molecule agonism at a peptide receptor.
cato_batista is right that milligram comparisons across classes tell you nothing.
comment on what would you tell week-1 you about non-peptide in c/orforglipron · 2 points · 12 months ago
Spent an evening reading about small-molecule agonism at a peptide receptor. Genuinely interesting engineering.
comment on does reimbursement actually matter or is it forum lore at this point in c/glp1eu · 9 points · 12 months ago
Are you comparing the same presentation, or different pack sizes?
comment on does reimbursement actually matter or is it forum lore at this point in c/glp1eu · 13 points · 12 months ago
Correction: that is the authorisation position, and the question was about reimbursement. Different bodies, different answers.
comment on genuine question about titration that I am slightly embarrassed to ask in c/semaglutide · 80 points · 1 year ago
STEP-1 ran 68 weeks and landed just under 15% mean body weight change on 2.4mg. It is an average of a wide distribution, not a target you have missed.
comment on the Netherlands: EMA, and what it actually costs here in c/glp1eu · 170 points · 1 year ago
Nothing here is medical or legal advice, and eligibility questions have national answers that a pharmacist where you live can give you in minutes.
comment on gallbladder: the version I wish someone had shown me in week 1 in c/sideeffects · 1 points · 1 year ago
Kept a one-line-a-day log for two months. The pattern was obvious on paper and invisible in my head.
comment on what changed for me between month 3 and month 6 in c/orforglipron · -27 points · 1 year ago
oral and non-peptide is the whole engineering story
comment on [Results] 37 weeks, 6kg, and weekly dosing was the hard part in c/semaglutide · 6 points · 1 year ago
Correcting myself from earlier in the thread: I said week 6 and it was week 14. Same shape, wrong number.
37 weeks, 6kg, and weekly dosing was the hard part. Full detail below, and I have tried to keep the editorialising out of it. Numbers, in the order they matter: 37…
comment on the province thing finally clicked for me and I want to write it down in c/glp1canada · 16 points · 1 year ago
That is an employer plan process, and the provincial route is different in both form and timeline.
comment on unpopular opinion: most of what gets said here about MHRA is guesswork in c/glp1uk · 4 points · 1 year ago
Discharge from a specialist service at goal is a normal end point of that pathway. Whether prescribing continues in primary care afterwards is a local decision and is worth asking about at the start rather than at the end.
comment on stalled for 6 weeks at 15mg and I refuse to panic this time in c/sideeffects · 31 points · 1 year ago
Reflux was the one that got me. Stopped eating in the three hours before bed and it went from nightly to almost never.
comment on stalled for 6 weeks at 15mg and I refuse to panic this time in c/sideeffects · 1 points · 1 year ago
Correcting my own comment above: I said day three and my log says day two. Same pattern, wrong day.
comment on [Meta] proposal — a flair for Ozempic posts in c/semaglutide · 84 points · 1 year ago
Steady state after a dose change takes four to five half-lives, so the fair judgement point on a new step is about a month, not four days.
comment on the Wegovy question that gets asked weekly, answered properly in c/semaglutide · 200 points · 1 year ago
staying at 2.4mg for an extra month is a legitimate plan
comment on [Meta] the private prescription rule is doing its job and people should stop complaining in c/glp1uk · 1 points · 1 year ago
the Irish scheme cap is the single most useful fact in this board
comment on [Discussion] the ACHIEVE advice in here is 3 years out of date in c/orforglipron · 45 points · 1 year ago
Because it is not a peptide, it is not subject to the same degradation pathways, does not require the absorption enhancers used for oral peptides, and can be formulated as a conventional tablet.
comment on someone explain UK to me like I have not read a paper in years in c/glp1uk · 10 points · 1 year ago
Small fix — that is the Scottish pathway. The post is asking about England and the answer is different.
comment on [Meta] the 2.4mg rule is doing its job and people should stop complaining in c/semaglutide · 38 points · 1 year ago
Small correction: 2.4mg is the maintenance ceiling on the label, not the starting maintenance dose. The distinction matters for anyone reading this later.
comment on [Lab] QYB orfo — Medutest came back 99.2% against a claimed 99.0% in c/orforglipron · 39 points · 1 year ago
do not assume reconstitution intuitions apply, there is nothing to reconstitute
QYB orfo — Medutest came back 99.2% against a claimed 99.0%. One vial, one service, one member paying, which is the only kind of result this board should treat as…
comment on [Question] how do you actually verify special authorization in c/glp1canada · 172 points · 1 year ago
quantity limits are as common a barrier as coverage itself
comment on the NHS question that gets asked weekly, answered properly in c/glp1uk · 33 points · 1 year ago
Disagree. That is the pathway in one ICB and it does not generalise even to the next one over.
comment on [Question] food noise — what am I missing here in c/semaglutide · 338 points · 1 year ago
Disagree. 2.4 is the top of the label, not the goal, and "everyone ends up there" is just survivorship in the posts you read.
comment on [Meta] proposal — a flair for UK posts in c/glp1uk · 571 points · 1 year ago
England, Scotland, Wales and Northern Ireland are four different pathways
comment on [Meta] the heart rate rule is doing its job and people should stop complaining in c/sideeffects · 15 points · 1 year ago
Severe or persistent abdominal pain sits outside the pattern this board can usefully discuss. The honest answer there is that it needs someone who can examine you.
comment on [Results] 96 weeks, 40kg, and 2.4mg was the hard part in c/semaglutide · 22 points · 1 year ago
Dropped my injection day by two days once because of travel. Nothing happened. The panic was worse than the effect.
comment on [PSA] Wegovy is not what most of this community thinks it is in c/semaglutide · 111 points · 1 year ago
The mental model that finally made this click for me: there are two curves, and people watch the wrong one.
Right, and the timescale is the bit that keeps getting lost. Judge a step at a month, not at a weekend.
comment on [PSA] Wegovy is not what most of this community thinks it is in c/semaglutide · 54 points · 1 year ago
That figure is the 68-week trial mean, not a weekly rate. Dividing it by the weeks gives you a number that does not mean anything.
comment on three years of Ozempic threads, summarised so you do not have to read them in c/semaglutide · 129 points · 1 year ago
staying at 0.5mg for an extra month is a legitimate plan
comment on [Results] 58 weeks, 21kg, and plateau was the hard part in c/semaglutide · 1 points · 1 year ago
Week 19: 8kg down, constipation basically gone since about week 9, and the honest headline is that nothing dramatic happened. It was boring and it worked.
comment on three years of tier 3 threads, summarised so you do not have to read them in c/glp1uk · 93 points · 2 years ago
In England, specialist weight management services are commissioned locally, so eligibility criteria and waiting times differ by ICB. There is no single national threshold to quote.